RTI Surgical

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

RTI Surgical - OEM Business designs, develops, manufactures and distributes biologic, metal and synthetic implants for a global customer base. Its implants are used in a variety of surgical procedures including orthopaedic, spine, sports medicine, general surgery and trauma.

DEERFIELD, Ill., March  03, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended (the “HSR Act”), with respect to the proposed sale (the “Sale”) of RTI’s OEM business to Ardi Bidco Ltd., a Delaware corporation and an entity affiliated with Montagu Private Equity, LLP (the “Buyer”), expired at 11:59 p.m. Eastern Time on February 28, 2020.

RTI Surgical Holdings, Inc.® Announces Expiration of Hart-Scott-Rodino Waiting Period With Respect to Sale of OEM Business

Interim results in the EVoluSIon Study on the SImmetry® System further show 78 percent of patients are opioid-free at 24 months Interim results in the EVoluSIon Study on the SImmetry® System further show 78 percent of patients are opioid-free at 24 months

RTI Surgical® Releases Data on the SImmetry® System Showing 98% of Treated SI Joints Demonstrate Evidence of Fusion

DEERFIELD, Ill., Feb.  25, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced today that it has postponed the special meeting of its shareholders, which was scheduled for March 31, 2020 (the “Special Meeting”) to, among other things, consider and vote on various proposals necessary to close the previously announced Equity Purchase Agreement, dated January 13, 2020, with Ardi Bidco Ltd., a Delaware corporation and an entity affiliated with Montagu Private Equity, LLP (the “Buyer”), pursuant to which the Buyer will acquire the OEM business of the Company by means of a sale (the “Sale”) of certain affiliates of the Company. 

RTI Surgical Holdings, Inc.® Announces Postponement of Record Date and Stockholder Meeting Date for Sale of OEM Business

DEERFIELD, Ill., Jan.  28, 2020  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced today that it has set the record date for the special meeting of its shareholders to, among other things, consider and vote on various proposals necessary to close the previously announced Equity Purchase Agreement, dated January 13, 2020 (the “Purchase Agreement”), with Ardi Bidco Ltd., a Delaware corporation and an entity affiliated with Montagu Private Equity, LLP (the “Buyer”), pursuant to which the Buyer will acquire the OEM business (the “Business”) of the Company by means of a sale (the “Sale”) of certain affiliates of the Company.

RTI Surgical Holdings, Inc.® Announces Record Date and Stockholder Meeting Date for Sale of OEM Business

RTI Surgical: Focus On Spine Performance

Compugen

Glu Mobile

GameStop

Groupon

Interpace Diagnostics

Meet Group

OrganiGram Holdings Inc.

Synlogic

Zynga

With stocks at all time highs and after the Dow rose more than 22% and the S&P 500 rose over 28% in 2019, many investors have yet to make many changes in the portfolios for what could be another solid 2020.

10 Stocks Trading Under $10 With Massive Upside Potential in 2020

The company announced a lucrative business transaction and provided a sneak peek at fourth-quarter results.

Here's Why RTI Surgical Holdings Stock Is Skyrocketing Today

Study finds PEKK displayed potential advantages to bone growth characteristics when compared to PEEK and Titanium-coated PEEK in an ovine bone defect model Study finds PEKK displayed potential advantages to bone growth characteristics when compared to PEEK and Titanium-coated PEEK in an ovine bone defect model

RTI Surgical® Announces The Spine Journal’s Publication of In Vivo TETRAfuse® 3D Technology PEKK Study

Terry Rich, experienced spine leader, named President, Global Spine ;  Olivier Visa elevated to President, Global OEM

RTI Surgical® Accelerates Business Transformation with Senior Leadership Appointments

RTI Surgical Holdings, Inc. (RTIX) CEO Camille Farhat on Q3 2019 Results - Earnings Call Transcript

DEERFIELD, Ill., Oct.  17, 2019  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced it plans to release financial results from the third quarter 2019 on Thursday, October 31, 2019, prior to the market open.

RTI Surgical® Schedules Third Quarter 2019 Earnings Call for October 31, 2019

RTI announces interim clinical outcomes on 150 patients at 6-month follow-up in the EVoluSIon study for the SImmetry® Sacroiliac Joint Fusion System showing statistically significant reductions in pain of 56% and opioid use of 45% RTI announces interim clinical outcomes on 150 patients at 6-month follow-up in the EVoluSIon study for the SImmetry® Sacroiliac Joint Fusion System showing statistically significant reductions in pain of 56% and opioid use of 45%

RTI Surgical® Showcases Advancements in Spine Portfolio and Clinical Data at NASS 2019

RTI expands its Established Therapies spine portfolio to further meet surgeon and patient needs RTI expands its Established Therapies spine portfolio to further meet surgeon and patient needs

RTI Surgical® Announces Commercial Launch of the CervAlign® Anterior Cervical Plate System

DEERFIELD, Ill., Sept.  23, 2019  (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced Camille Farhat, President and Chief Executive Officer, and Jonathon Singer, Chief Financial and Administrative Officer, are scheduled to present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, October 2, at 2:25 p.m. EDT in New York City.

RTI Surgical® to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference in New York City

The HPS 2.0 system incorporates clinically proven technology to significantly reduce the risk of adjacent segment degeneration The HPS 2.0 system incorporates clinically proven technology to significantly reduce the risk of adjacent segment degeneration

RTI Surgical® Announces First Spine Surgery Using the HPS™ 2.0 Hybrid Performance System

RTI Surgical Holdings, Inc. (RTIX) CEO Camille Farhat on Q2 2019 Results - Earnings Call Transcript

RTI Surgical Holdings, Inc. (RTIX) CEO Camille Farhat on Q1 2019 Results - Earnings Call Transcript

News for RTI Surgical Stock (RTIX)